美國Caliper  www.caliperls.com
美國Caliper Life Sciences主要為在生命科學領(lǐng)域內(nèi)致力于挽救生命、快速有效地提高藥效和診斷測試水平的研究人員提供尖端技術(shù)。公司正積極通過技術(shù)創(chuàng)新來縮小體內(nèi)和體外實驗結(jié)果之間的差距，并研究如何有效地將之應用于疾病的治療。該公司的主要產(chǎn)品包括先進的微流體、實驗室自動化和液體處理、光學成像及開發(fā)外包方案等。
2006年Caliper 收購 Xenogen公司
2011年珀金埃爾默(PerkinElmer)6億美元收購Caliper 

Caliper Life Sciences (NASDAQ: CALP) is a leading provider of cutting-edge technologies enabling researchers in the life sciences to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper has compiled numerous best-in-class solutions and is aggressively innovating new technologies to bridge the gaps that exist in bringing in vitro assays to in vivo results and ultimately into cures for human disease. With a keen focus on clinically-relevant experimentation, Caliper’s portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions.
Our company represents a community of intelligent, highly-motivated people dedicated to working together as a team to improve the human condition through innovation in life sciences research. We maintain world headquarters in Hopkinton, Massachusetts, and direct sales, service and application-support operations in biopharmaceutically-active countries around the globe. Caliper’s customers and partners include leading pharmaceutical companies like Pfizer, GlaxoSmithKline, Sanofi-Aventis, Novartis, and AstraZeneca, among others.